Role of Cardiac Magnetic Resonance in the Assessment of Patients with Premature Ventricular Contractions: A Narrative Review
1Department of Cardiology, Institute for Cardiovascular Diseases, Iași, Romania;University of Medicine and Pharmacy, Iași, Romania
2University of Medicine and Pharmacy, Iaşi, Romania;Internal Medicine Clinic, Emergency Clinical County Hospital, Iași, Romania
3Department of Cardiology, Institute for Cardiovascular Diseases, Iași, Romania
Anatol J Cardiol 2024; 28(10): 467-478 PubMed ID: 38832526 PMCID: PMC11460551 DOI: 10.14744/AnatolJCardiol.2024.4314
Full Text PDF

Abstract

Premature ventricular contractions (PVCs) are a common finding in clinical practice, requiring a full diagnostic work-up in order to exclude an underlying cardiomyopathy. Still, in a substantial proportion of patients, these investigations do not identify any substrate, and the PVCs are labelled as idiopathic. Cardiac magnetic resonance (CMR) has proven in the last decades as the method of choice for the exploration of patients with cardiomyopathies, since it can identify subtle changes in the myocardial tissue and help with risk stratification. In patients with idiopathic PVCs and a high PVC burden, several studies report the presence of late gadolinium enhancement (LGE) at CMR, which can offer additional diagnostic and prognostic benefits, as well as assistance in catheter ablation procedures, as the risk for adverse cardiac and risk for arrhythmic events events is higher compared to patients without scar. This paper focuses on the impact of the presence of LGE in patients with idiopathic PVCs, reviewing all the relevant studies published so far, including randomized controlled clinical trials, prospective or retrospective cohort studies, case series and case reports as well as systematic reviews.